A Brief Overview of the Players: Excitatory Synapses, Metalloproteinases, and Cell Adhesion Molecules
=====================================================================================================

Excitatory Synapses in the Central Nervous System (CNS)
-------------------------------------------------------

Changes in the number, structure, and/or function excitatory glutamatergic synapses are critical to experience dependent plasticity ([@B104]; [@B73]). In a simplified view, the majority of these synapses are dipartite structures consisting of pre-synaptic axon terminals from which transmitter is released and post-synaptic neurotransmitter receptor-bearing dendritic spines. The latter are small protrusions of varied size and shape that emerge from the dendritic shaft of glutamate-responsive neurons ([@B4]). Spines with relatively large diameter heads or a mushroom-like morphology tend to be comparatively more stable and to have an increased α-amino-3-hydroxy-5methyl-4-isoxazoleproprionic acid (AMPA) receptor (GluA) number ([@B93]; [@B73]; [@B19]; [@B92]; [@B65]). Importantly, neuronal activity dependent spine head enlargement, with a concomitant increase in synaptic incorporation of GluAs, is thought to underlie lasting enhancement of synaptic transmission or long-term potentiation (LTP). In a more complex view, glutamatergic synapses can be appreciated as multipartite sites in which glial cell processes approximate pre- and post-synaptic contact sites. Glial cells, or their soluble products, may thus modulate the structural and functional dynamics of neurotransmission ([@B36]).

Metalloproteinases in the CNS
-----------------------------

Metzincin proteases are zinc-dependent endopeptidases that include cell-secreted matrix metalloproteinases (MMPs) and transmembrane spanning adamalysins \[a disintegrin and metalloproteinase (ADAMs)\]. These proteases are increasingly appreciated as important effectors of brain function \[reviewed in [@B131], [@B57], [@B152]\]. Though a variety of MMPs and ADAMs are expressed in man, including more than 23 MMPs identified to date ([@B116]), it should be noted that a select subset is likely relevant to physiological and pathological CNS plasticity. Family members with well-described expression in neurons, astrocytes, or microglia include MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-12, MMP-13, MMP-14, and a disintegrin and metalloproteinase-10 (ADAM-10; [@B186]; [@B167]).

The cell regulates overall activity of specific MMP and ADAM family members at several levels including that of gene expression. At the transcriptional level, activator protein 1 (AP-1) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) increase the expression of varied family members such as MMP-9 ([@B42]; see also Table 1 of [@B15] for more on transcription factors and select MMPs). In contrast the transcription factor Yin Yang 1 (YY1) directs histone modification to strongly repress transcription of MMP-9 ([@B135]). While less is known about the regulation of ADAM family member expression, we do know that the promoter for ADAM10 contains several transcription factor binding-sites including a retinoic acid-responsive element where retinoic acid receptors and retinoic X receptors can bind and thereby activate gene expression ([@B126]; [@B162]). Retinoic acid receptors are present in synaptoneurosomes and dendrites and contribute to select forms of synaptic plasticity ([@B6]; [@B47]).

Post-translational regulation of MMPs and ADAMs is also important with respect to enzymatic activity. Since MMPs typically act on extracellular substrates, release mechanisms represent a potentially important point of control. In a study that activated fibrosarcoma cells with phorbol myristate acetate (PMA), it was shown that subsequent release of MMP-2 and -9 is soluble NSF attachment protein receptor (SNARE) dependent ([@B66]). The SNARE protein family is critical for calcium-dependent vesicular fusion and release from neurons ([@B44]; [@B154]). Since neuronal activity can increase intracellular calcium through mechanisms including activation of voltage gated calcium channels, it is tempting to speculate that calcium-dependent MMP release could be facilitated with the same. Of interest, MMP-2 and MMP-9 containing vesicles are observed in the somatodendritic compartment and found in dendritic spines ([@B142]; [@B179]). Moreover, stimuli that may increase intra-neuronal calcium and can induce LTP, can also evoke local MMP-9 release ([@B177]).

With respect to transmembrane spanning ADAMs, localization is also regulated. For example, ADAM10 and ADAM17 are mainly associated with the endoplasmic reticulum (ER) and Golgi apparatus, with little protein present at the plasma membrane ([@B143]; [@B49]). ADAM10 contains an ER retention signal at its C-terminus, suggesting that unidentified proteins are required for the ER exit and transport of this protease to the plasma membrane ([@B89], [@B88]). The binding of tetraspanins to ADAM10 ([@B184]; [@B127]) can promote ADAM10 exit from the ER. Synapse-associated protein-97 (SAP-97), a cargo protein involved in protein trafficking at excitatory synapses, can bind to proline-rich sequences in the cytosolic domain of ADAM10 ([@B88]). *N*-methyl-[D]{.smallcaps}-aspartate receptor (GluN) activation has been shown to affect phosphorylation of SAP97, as well as the transport of ADAM10 from Golgi outposts to synaptic membranes ([@B140]).

The activation of appropriately localized proteases represents an additional point of control. In the case of MMPs, this is typically achieved following release from the cell through cleavage of the pro-domain by other metalloproteinases or plasmin ([@B105]). Cleavage of the pro-domain disrupts a critical Cys-Zn^2+^ interaction that otherwise blocks substrate processing ([@B169]). Non-proteolytic activation of MMPs, however, also occurs. For example, nitration or oxidation may alter tertiary structure to activate pro-forms ([@B48]). Though less well-studied, MMPs may also be active within the cell ([@B176]).

Finally, MMP activity can be quenched by processes including low density lipoprotein receptor dependent internalization ([@B50]), and non-covalent interactions with endogenous tissue inhibitors of metalloproteinases (TIMPs; [@B43]; [@B173]; [@B21]).

In terms of brain plasticity related mechanisms that impact MMP expression, release and/or activity, several stimuli or stressors have been studied (see **Table [1](#T1){ref-type="table"}** for a partial summary). These include seizure activity ([@B187]; [@B158]), cytokines ([@B68]; [@B113]; [@B11]), neurotrophins ([@B74]), chronic stress ([@B166]), spatial learning ([@B183]; [@B97]), head trauma ([@B121]; [@B69]), cocaine ([@B23]; [@B150]), methamphetamine ([@B83]), modafinil ([@B54]), ischemia ([@B124]; [@B132]), and viral infection of the central nervous system (CNS; [@B31]; [@B62]; [@B118]; [@B189]). Upregulation of MMP-9 mRNA and enzymatic activity has also been documented in response to neuronal depolarization by KCl ([@B175]) and kainate ([@B158]; [@B72]; [@B179]; [@B134]). MMP-9 levels are increased with LTP ([@B107]), and MMP-9 mRNA can be transported to dendrites to undergo local translation and protein release following glutamate stimulation ([@B37]). Brain-derived neurotrophin factor (BDNF) also upregulates MMP-9 at the mRNA, protein, and enzymatic activity level in dendrites. This process requires engagement of TrkB receptors with subsequent activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and binding of c-Fos to the proximal MMP-9 promoter region ([@B74]). In contrast, MMP gene expression can be suppressed by factors including TGF-β, the anesthetic propofol ([@B188]), retinoic acid ([@B115]; [@B79]; [@B185]), or sleep deprivation ([@B159]).

###### 

Stimuli and stressors linked to altered MMP levels in the CNS.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Effector(s)                                                     MP(s)             Regional focus                                                                  Model system                  Findings and/or biological relevance                                                                                                                                          Reference
  --------------------------------------------------------------- ----------------- ------------------------------------------------------------------------------- ----------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------
  Seizure induction with kainate                                  MMP-2 and -9      Hippocampus, striatum, diencephalon, midbrain, frontal cortex, and cerebellum   Rat                           \(1\) Increased MMP-2 and -9 activity\                                                                                                                                        [@B187], [@B158]
                                                                                                                                                                                                  (2) Increased GFAP immunoreactivity in hippocampus and frontal cortex                                                                                                         

  Hippocampal dependent learning and memory (Morris water maze)   MMP-3 and -9      Hippocampus and prefrontal cortex                                               Rat                           \(1\) Increased MMP-3 and -9 protein                                                                                                                                          [@B183], [@B97]

  Chronic stress                                                  MMP-9             CA1 region of hippocampus                                                       Rat                           \(1\) Increased MMP-9\                                                                                                                                                        [@B166]
                                                                                                                                                                                                  (2) Reductions in Nectin-3                                                                                                                                                    

  Traumatic brain injury                                          MMP-3             Hippocampus                                                                     Rat                           \(1\) Astrocyte-derived MMP-3 levels and activity increase 7 days after induction of traumatic brain injury                                                                   [@B69]

  Ischemia                                                        MMP-2 and MMP-9   Hippocampus, lateral cortex, and striatum                                       Rat                           \(1\) MMP-9 levels increase at 4 h post injury\                                                                                                                               [@B124], [@B132]
                                                                                                                                                                                                  (2) MMP-2 levels peak at 4 days post injury, which corresponds with an increase in reactive microglia and macrophage infiltration                                             

  Viral infection                                                 MMP-2 and -9      Cerebral spinal fluid (CSF)                                                     Human (cerebrospinal fluid)   Damage to the blood--brain barrier (BBB) may facilitate the CNS ingress of monocytes that mediate brain injury. Select MMPs, such as MMP-2 and -9, can reduce BBB integrity   [@B31]

  Psychostimulants (methamphetamine, cocaine, and modafinil)      MMP-9             Hippocampus, medial prefrontal cortex                                           Rat                           Data suggest that MMP-9 expression may be involved in the addiction phenotype and/or remodeling of the nervous system                                                         [@B23], [@B83], [@B54]
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

While a wide variety of studies have examined MMP and ADAM expression in brain or brain-derived cell cultures as a function of specific stimuli, CNS changes have also been examined in a limited number of mutant mouse models. A summary of results from studies using this approach is shown in **Table [2](#T2){ref-type="table"}**.

###### 

Altered neuronal migration and/or plasticity in mutant mouse models.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Animal model                                               Regional focus            Results                                                                                                                                  Reference
  ---------------------------------------------------------- ------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- -----------
  MMP-3 knock out mouse                                      Cerebellum                \(1\) Increased size of the external granular layer (EGL) and enhanced granule progenitor cell proliferation at post-natal days 8--12\   [@B168]
                                                                                       (2) Delayed migration of granule cells to the EGL\                                                                                       
                                                                                       (3) Decreased length and complexity of Purkinje cells at post-natal day 12                                                               

  MMP-3 knock-out mouse                                      Visual cortex (layer V)   \(1\) Decreased dendritic length and increased number of apical oblique dendrites in pyramidal neurons                                   [@B1]

  MMP-9 overexpressing rat                                   Hippocampus               \(1\) Increased length of dendritic spines in CA1                                                                                        [@B100]

  MMP-9 knock-out mouse                                      Cerebellum                \(1\) Increased granule precursor cell number and decreased apoptosis in the external granular layer at post-natal day 12                [@B165]

  MMP-9 knock-out mouse                                      Hippocampus (slices)      \(1\) Impaired magnitude and duration of LTP                                                                                             [@B107]

  MMP-2/-9 double knock-out mouse                            Nucleus accumbens         \(1\) Decreased sensitization and reward behavior following methamphetamine (2 mg/kg) administration                                     [@B102]

  MMP-2 and MMP-9 single knock out mice (observed in both)   Cerebral cortex           \(1\) Increased number of cell in cerebral-cortical layers 2--3\                                                                         [@B161]
                                                                                       (2) Altered ICAM-5 and L1CAM levels as a function of age                                                                                 

  ADAM-10 knock-out mouse                                    Hippocampus               \(1\) Decreased neural progenitor cell number with increased differentiation toward the neuronal lineage\                                [@B190]
                                                                                       (2) Impaired performance on a hippocampal-dependent test of memory                                                                       

  MMP-9/-12 double knockout                                  Corpus callosum           \(1\) Decreased myelination at post-natal day 7\                                                                                         [@B75]
                                                                                       (2) Decreased oligodendroglial cell number at post-natal day 10                                                                          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CAMs in the CNS
---------------

Cell adhesion molecules represent transmembrane adhesion molecules expressed at cell contact sites including the synapse. These molecules typically belong to one of several superfamilies which include cadherins, neurexins/neuroligins, and Ig-domain containing members \[reviewed in [@B12]\]. CAMs can mediate stable cell--cell junctions and select family members also play a role in the initiation of synapse formation. Cell surface levels of these molecules, as well as adhesive contact strength, are modified by processes including clathrin-dependent endocytosis ([@B64]). In addition, varied transmembrane CAMs have important intracellular interactions. For example, while integrin cytoplasmic tails do not possess endogenous kinase activity, they interact with critical effectors of intracellular protein phosphorylation cascades ([@B28]). Finally, through cis-interactions, transmembrane CAMs may influence the localization of synaptic proteins. As a potential example, *N*-cadherin, GluN1 and L1 are found together in large multiprotein complexes ([@B58]) suggesting that GluN may be part of a membrane adhesion complex ([@B146]).

Accumulating evidence demonstrates that disrupted CAM expression can influence experience dependent plasticity. For example, ablation of *N*-cadherin from excitatory forebrain synapses of post-natal mice is associated with an alteration in the composition of glutamatergic synapses, so that levels of the GluA1 subunit and PSD95 are diminished ([@B111]). Earlier work by the same group has shown that a conditional *N*-cadherin knockout causes a reduction in the maintenance, but not induction, of LTP ([@B20]). These studies are of particular relevance in that conditional ablation of *N*-cadherin addresses potential confounds that might be associated with knockout effects on early brain development.

Neuron-specific deletion of dystroglycan, a transmembrane protein that links extracellular matrix and the cytoskeleton, also reduces LTP. Specifically, neuron-specific deletion of this protein is associated with a blunting of high frequency stimulation (HFS) induced LTP at CA3--CA1 synapses ([@B141]). Dystroglycan is expressed by varied cell types including glia, and glial expression of the molecule is involved in forebrain development ([@B141]).

A number of studies have also investigated LTP in mice that lack specific Ig-domain CAM family members \[comprehensively reviewed in [@B35]\]. Neural cell adhesion molecule (NCAM) is a homophilic binding protein that is expressed on the surface of neurons and glia and has been implicated in neurite outgrowth and synaptic plasticity. Indeed, NCAM-deficient mice show impaired LTP in area CA3 ([@B33]), and impaired LTP in NCAM knockouts can be rescued by increasing GluN dependent glutamate transmission ([@B71]). In related work, [@B33] studied mice with a targeted deletion of a polysialyltransferase that attaches polysialic acid (PSA) to NCAM, and that is expressed predominantly in post-natal life ([@B38]). These animals were shown to have lower post-natal levels of PSA in the brain as well as impaired LTP in CA1 that is evident by 4 weeks of age. Mice that are deficient in ICAM-5, an additional Ig-domain family member expressed on excitatory neurons of the telencephalon ([@B114]; [@B13]), also show changes in glutamatergic synapses. These animals show an increase in the dendritic spine/filopodia ratio at P7, suggesting that full length ICAM-5 may delay spine maturation ([@B91]). Though full length ICAM-5 is gradually excluded from spines during their developmental maturation, it remains in approximately 60 percent of spines in adult hippocampal neurons ([@B137]; [@B91]). An antibody directed against ICAM-5, which would presumably disrupt adhesive interactions important to filopodial maintenance, inhibits LTP in rat hippocampus ([@B137]). In mouse hippocampus, however, LTP is relatively increased in an ICAM-5 null animal ([@B108]). Though confounds include antibody specificity, as well as developmental and compensatory effects in the knockout, results are of interest with respect to ICAM-5 as a potential modulator of glutamatergic function.

Specific neuroligin family members have also been investigated with respect to glutamatergic transmission. These are cell adhesion proteins on the post-synaptic membrane that mediate the formation and maintenance of synapses between neurons. Neuroligins act as ligands for β-Neurexins, which are located on the presynaptic membrane. Of particular interest is a study of an autism-associated point mutation in the neuroligin tail that was evaluated following generation of a knock-in mouse ([@B39]). Whole-cell voltage-clamp recordings in hippocampal CA1 pyramidal neurons from the knock-in showed a decrease in mini excitatory post-synaptic current (mEPSC) frequency but not amplitude. Changes in GluA receptor subunit composition or presynaptic release possibility were excluded by additional studies, and it was suggested that the neuroligin-3 cytoplasmic tail modulates recruitment of GluAs to post-synaptic sites of excitatory synapses ([@B39]).

In addition to *in vitro* and animal model based studies, human genetic studies are consistent with an important role for CAMs in neuroplasticity. Mutations in contactin-associated protein 2, which may promote neuronal circuit assembly during development ([@B5]), predispose to autism. Moreover, polymorphisms in CAMs including cadherin 13 ([@B61]; [@B164]) are associated with addiction risk.

Synaptic CAMs: Perfectly Poised Substrates for Neuronal Activity Dependent Cleavage
===================================================================================

Though a role for CAMs in processes such as LTP could be in whole or large part secondary to the function of full-length molecules, it should also be considered that synaptically localized CAMs represent especially attractive targets for neuronal activity dependent proteolysis. CAM cleavage could disrupt stable interactions with exogenous CAM ligands and/or cause additional effects, including generation of bioactive or dominant negative receptor fragments. Varied CAMs are expressed at synaptic contacts including *N*-cadherin, L1-CAM, ICAM-5, DSCAM, syndecan 2, syncam 2, and neuroligin ([@B13]; [@B120]; [@B152]), and activity-dependent, membrane-proximal cleavage of these molecules is supported by *in vitro* studies that have demonstrated juxtamembrane shedding for specific family members ([@B120]; [@B152]). Data from analysis of cerebrospinal spinal fluid samples also supports shedding of CAMs ([@B153]). In this case, shed CAMs likely access the interstitial space from where they in turn gain access to CSF. In one study, an increase in levels of soluble ICAM-5 ectodomain was detected in the CSF of patients with epilepsy and/or infection ([@B82]; [@B160]). In related work, N terminal sequencing of NCAM fragments from the CSF of patients with schizophrenia was performed and a disease-associated increase in levels of ectodomain fragments observed ([@B170]).

Regulated cleavage of synaptic CAMs can influence glutamatergic transmission through several non-mutually exclusive mechanisms including reduced synaptic stability, conversion of N-terminal CAM ectodomains into soluble effectors of plasticity, and increased generation of intracellular domains (ICDs) that influence transcription. With respect to ICD generation, it should be noted that ectodomain shedding of CAMs is frequently followed by intramembranous gamma secretase cleavage to generate specific C terminal fragments \[reviewed in [@B63]\].

Activity Dependent Cleavage of Neuroligin and *N*-Cadherin
----------------------------------------------------------

Though it has been suggested that ectodomain shedding is highly regulated with only 2% of cell surface proteins released by this process ([@B53]), emerging evidence suggests that neuronal activity dependent CAM shedding represents an important mechanism by which synaptic structure and function are modulated. For example, neuronal activity dependent cleavage of neuroligin-1 is triggered by GluN activation and dependent on MMP or ADAM activity ([@B120]; [@B156]). It occurs in a membrane proximal location and results in destabilization of neuroligin-1's presynaptic partner, neurexin-1β. Destabilization of neurexin is in turn thought to reduce the probability of presynatic neurotransmitter release ([@B120]).

GluN agonists, as well as ADAM and MMP family members that are regulated in a neuronal activity dependent manner, have also been linked to *N*-cadherin shedding ([@B129]; [@B163]; [@B181]; [@B119]; [@B125]). One of many potential sequelae of this event is the associated generation of a C terminal fragment which is quickly processed by gamma secretase to generate a smaller intracellular fragment that destabilizes a protein critical for CREB dependent transcription ([@B87]).

Activity Dependent Cleavage of Ig-domain CAMs
---------------------------------------------

In work related to a potential role of ICAM-5 shedding in developmental plasticity, it has been shown that long term treatment (16 h) of DIV 14 hippocampal neurons with 5 μM NMDA or AMPA stimulated an MMP-dependent increase in supernatant levels of shed ICAM-5. ICAM-5 is expressed on dendritic elements of excitatory/spiny neurons in the telenchephalon ([@B13]). Since full length ICAM-5 may be a negative regulator of filopodia-to-spine transition ([@B91]), these findings are consistent with the possibility that ICAM-5 shedding contributes to developmental spine maturation.

Studies related to the possibility that ICAM-5 cleavage may occur in a relatively rapid manner to influence activity dependent glutamatergic transmission in the adult CNS have also been performed. NMDA stimulation of cultured hippocampal neurons and high frequency tetanic stimulation of hippocampal slices have both been linked to relatively rapid MMP-dependent ICAM-5 shedding ([@B30]). In cultured cells, appreciable release of soluble ICAM-5 into culture supernatants can be detected within 5 min of NMDA exposure ([@B30]).

Additional studies have examined neuronal activity dependent cleavage of nectin-1, an Ig-like adhesion molecule expressed at puncta adherentia junctions in the CA3 pyramidal region of adult mouse hippocampus ([@B81]). Of interest, *in vitro* over-expression of cleavage resistant mutants of nectin 1 is associated with an increase in the density of dendritic spines ([@B81]). One possibility is that cleavage resistant mutants might lead to an increase in the stability of spines.

Elegant work on a related adhesion molecule, demonstrated enhanced MMP-9 dependent cleavage of nectin-3 in perisynaptic CA1 in the setting of chronic stress ([@B166]). Intriguingly, inhibition of MMP-9 activity or GluN activation led to a reduction chronic stress related behavioral alterations.

IgLON family members, abundant GPI anchored transmembrane proteins, are also processed in a metalloproteinase dependent manner. The IgLON family is a subgroup of the immunoglobulin superfamily cell adhesion molecules (CAMs) and composed of limbic system-associated protein (LAMP), opioid binding cell adhesion molecule (OBCAM), neurotrimin (NTM) and Kilon. Long term treatment of hippocampal neurons with a broad spectrum MMP inhibitor and subsequent pull down of surface proteins demonstrated that inhibitor-treated neurons show increased levels of specific IgLON family members including NTM ([@B139]).

Glutamate and MMP dependent shedding of synaptic cell adhesion molecule 2 (SynCAM-2) has also been described ([@B9]), which is of interest given the role of this molecule in synapse organization and function ([@B16]; [@B40]).

Emerging and Future Studies of Neuronal Activity Dependent CAM Cleavage
-----------------------------------------------------------------------

Matrix metalloproteinases and ADAMs can also act on a variety of less traditional CAMs including nerve-glia antigen 2 (NG2), β-dystroglycan, and amyloid precursor protein (APP) and netrin-G ligand-3 ([@B2]; [@B99]; [@B76]; [@B136]). There is evidence that these molecules are shed in a neuronal activity-dependent manner, and that they play a role in developmental and/or adult plasticity. For example, recent work suggests that glutamatergic transmission is altered in NG2 knockout animals ([@B136]). Future studies will be necessary to further explore mechanisms by which shedding of these proteins can influence plasticity.

Future studies will also be necessary address issues related to shedding of dimers versus monomers, as well as issues of whether single nucleotide polymorphisms (SNPs) influence shedding. Results from recent work suggest that ADAM dependent shedding of neuregulin-1 requires prior dimerization ([@B52]), and analysis of soluble ICAM-1 in pleural fluid suggests that this molecule may also be shed as a dimer ([@B98]).

Future studies could additionally explore the question of whether post-translational modifications such as glycosylation can influence the cleavage and/or bioactivity of protease-generated CAM fragments. And finally, unbiased proteomics could be utilized to examine interactions between shed CAMs and other proteins in the background of select physiological and pathological processes.

Metalloproteinases and Synaptic Transmission
============================================

Despite their ability to stimulate effects that could both enhance or depress neurotransmission, the majority of studies support a view in which non-pathological neuronal activity stimulates an MMP dependent enhancement of long term memory and its correlates. For example, several groups have demonstrated that MMP inhibitors reduce LTP stimulated by HFS and/or theta burst stimulation (TBS; [@B107]; [@B96]; [@B30]). Inhibition of MMP activity also reduces chemical LTP (cLTP) associated increases in the firing rate and bursting of dissociated cultures of primary hippocampal neurons ([@B110]).

Consistent with their effects on hippocampal LTP, varied biochemical and behavioral studies support a role for MMPs in hippocampal dependent learning and/or memory. For example, knockout of MMP-9 impairs contextual fear conditioning ([@B106]). Interestingly, in wild-type animals contextual fear conditioning increases hippocampal MMP-9 protein levels as well as MMP-9 dependent cleavage of dystroglycan ([@B42]). These data suggest that MMP-9 plays a role in hippocampal memory association and/or retention. It has also been shown that hippocampal MMP-3 and -9 mRNA levels are increased with Morris water maze (MWM) training, as are levels of active MMP-3 and -9 protein ([@B97]). Moreover, treatment with the non-competitive GluN antagonist, MK801, reduces training-associated increases in specific MMP levels, as well as post-training performance assessed by latency to reach platform. Intra-hippocampal or intra-cerebral ventricular injection of a broad-spectrum chemical MMP inhibitor, as compared to artificial CSF control injection, can also reduce time spent in the target quadrant during the MWM probe trial ([@B97]). Of interest with respect to anesthetic-modulation of learning and memory, it has been shown that while MWM training can induce a gradual increase in pro- and active-MMP-9, propofol can reduce this increase and also disrupt spatial memory retention 24 h after training ([@B188]). In contrast, the wake promoting agent modafinil increases MMP-9 expression in dorsal hippocampal CA3 in a model of REM sleep deprivation ([@B54]). In this same model, modafinil increases synapsin 1 expression in an MMP-9 dependent manner. In addiction-related plasticity work, it has been shown that context dependent learning of nicotine induced conditioned place preference (CPP) is associated with an increase in hippocampal MMP-2, -3, and -9 expression, and that exposure to a chemical MMP inhibitor during nicotine induced CPP training can block CPP acquisition ([@B109]). In addition, methamphetamine-induced behavioral sensitization is reduced in mice lacking MMP-2 or MMP-9 ([@B102]).

Matrix metalloproteinase activity can also contribute to enhanced glutamatergic transmission in regions including striatum and amygdala. For example, a chemical MMP inhibitor can disrupt reconsolidation of a fear memory associated with a conditioned stimulus that is independent of contextual cues ([@B24]). In studies with MMP-9 null mice, Kaczmarek and colleagues have shown that MMP activity in the central amygdala is required for appetitive but not aversive learning ([@B70]). In recent work related to cocaine and MMP levels in nucleus accumbens core, an increase in gelatinase activity as detected by *in situ* zymography was detected along neuronal soma and dendrites ([@B150]). AMPA/NMDA ratios were also increased in medium spiny neurons in cocaine extinguished rats and further increased by cue-induced reinstatement, in an MMP dependent manner. MSNs also showed MMP dependent changes in MSN spine head diameter and/or number in cocaine extinguished and reinstated animals ([@B150]).

Mechanisms by which MMPs Influence Neurotransmission; A Focus on CAM Cleavage as a Means to Generate Integrin-Binding Ligands
=============================================================================================================================

In terms of the mechanisms by which MMPs modulate actin and spine dynamics to enhance glutamatergic transmission, it should be noted that despite their potential to act on varied substrates such as proneurotrophins ([@B77]), evidence suggests that their ability to enhance LTP is β~1~ integrin dependent ([@B107]; [@B96]). Since changes in the number and size of dendritic spines are thought to underlie LTP, Huntley and colleagues ([@B177]) also monitored spine size and EPSPs simultaneously in hippocampal neurons with combined 2-photon time-lapse imaging and whole-cell recordings. These investigators observed that persistent spine enlargement and synaptic potentiation required both MMP activity and β~1~ integrins ([@B177]). In related studies, we have previously shown that a β~1~ integrin blocking antibody prevents cLTP associated increases in the overall firing rate of hippocampal-derived neurons ([@B110]).

Integrin signaling, and signaling through β~1~ containing integrins in particular, has been well-associated with changes in dendritic and spine actin dynamics ([@B55]; [@B147]). The majority of hippocampal integrin heterodimers contain a β~1~ subunit ([@B123]; [@B25]; [@B57]). In addition, β~1~ integrins are expressed on dendrites ([@B103]) and implicated in the regulation of post-natal dendritic arbor and synapse density ([@B178]). Antagonism of β~1~ integrin signaling by function blocking antibodies or GRGDS peptide administration is associated with a decay of LTP, and hippocampal infusion of function blocking antibodies to β~1~ blocks formation of long-term object location memory ([@B8]). Integrin like kinase is also involved in the induction and maintenance of cocaine sensitization, and its silencing prevents sensitization-associated serine-845 phosphorylation of GluA1 ([@B27]). Though a role for integrin signaling has been implicated in potentiated synaptic activity ([@B14]; [@B107]; [@B96]), the identity of physiologically relevant ligands and important mechanisms by which these ligands are generated has yet to be fully explored.

Recent work is consistent with the possibility that MMP-dependent CAM shedding represents a potential mechanism by which excitatory transmission generates integrin-binding ligands. As opposed to larger ECM components, CAM ectodomains may be relatively soluble. Indeed, previous studies have shown that cleavage of relatively large molecules does not necessarily disrupt three dimensional integrity of the same ([@B56]). Numerous studies, including those that have demonstrated the integrity of CAM N-terminal fragments in spinal fluid and tissue, support the concept of ectodomain solubility and stability ([@B82]).

Cell adhesion molecule ectodomains are known to possess integrin-binding motifs and indeed stable CAM/integrin interactions have been described ([@B29]; [@B67]; [@B112]). CAM ectodomains can also stimulate integrin dependent signaling. For example, shedding of the L1 adhesion molecule has been shown to stimulate integrin dependent cell migration ([@B95]). In addition, we have observed that soluble ICAM-5 can stimulate a β~1~ dependent increase in action potential frequency in cultured hippocampal neurons ([@B110]). We also observe co-immunoprecipiation of both full length and shed N terminal ICAM-5 with β~1~ in hippocampal lystates from methamphetamine challenged mice, suggesting that the shed ectodomain may interact with β~1~ *in vivo* ([@B29]). NCAM and NG2 can also interact with integrins, and though not yet tested for effects on integrin-dependent neurotransmission, dorsal hippocampal injection of PSA-NCAM has been shown to partially restore impaired contextual memory in NCAM deficient mice ([@B144]). Of interest, mice that overexpress the NCAM ectodomain show memory impairments that are similar to those observed in the knockout ([@B122]). This is consistent with a dominant negative effect as well as the possibility that dysregulated ectodomain shedding is deleterious, and it underlines our need to better explore the bioactivity of CAM ectodomains in both physiological and pathological conditions. A schematic of CAM ectodomain shedding from glia and/or neurons, with subsequent integrin binding, is shown in **Figure [1](#F1){ref-type="fig"}**.

![**Synaptically localized CAM cleavage.** Pre and post synaptic components (black outline) and glial components (green outline) of the synapse are shown. MMPs can be released from neurons and/or glia to cleave peri-synaptic CAMs, thus generating CAM N-terminal fragments with the potential to stimulate intregrin dependent signaling. Though not the focus of this review, cleavage generated CAM intracellular domains (ICDs) may also influence synaptic transmission.](fncel-09-00305-g001){#F1}

In terms of the functional consequences of MMPs and/or CAM ectodomains at single synapses to in turn affect LTP, several non-mutually exclusive possibilities exist as shown in **Figure [2](#F2){ref-type="fig"}**. In the first, supported by high resolution imaging ([@B177]), MMP activity causes a change in actin dynamics with a subsequent widening of spines. This would likely bring an increase in functional GluA receptors to the spine head and increase amplitude of mEPSCs. A second possibility is that MMP generated integrin binding ligands could stimulate the growth of new spines. Integrin signaling has been linked to the same ([@B147]), and though we did not observe a significant increase in spine number in ICAM-5 ectodomain stimulated DIV 14 rat hippocampal neurons at 1 or 24 h ([@B84]), it would be premature to rule out the possibility that this measure could be increased at other time points or following exposure to additional CAM ectodomains. The potential for integrin binding ligands to cause an unsilencing of post-synaptic components that were previously silent due to deficient synaptic levels of GluA receptors should be considered as a third possibility. Integrin signaling can activate protein kinases that would in turn phosphorylate specific GluA subunits to enhance their synaptic entry ([@B80]; [@B27]). Consistent with this possibility, in previous work we have observed both an ICAM-5 ectodomain stimulated increase in the phosphorylation and membrane localization of GluA1, and an increase in the frequency of mEPSCs ([@B84]). A fourth possibility is that MMP-dependent signaling stimulates in increase in spine head protrusions to affect glutamatergic transmission. While LTP is generally thought to represent an experience dependent increase in dendritic number and/or size ([@B73]), increased complexity of spines might also occur. It has been shown that MMP-9 can stimulate an increase in spine head protrusions ([@B157]). This finding is of significance in that these protrusions may be PSD-95 and GluA positive ([@B130]; [@B157]), and they may be functionally active in terms of mediating glutamateric neurotransmission ([@B130]).

![**Post-synaptic mechanisms by which MMP activity could enhance glutamatergic transmission.** There are several non-mutually exclusive possibilities by which MMP activity could influence excitatory neurotransmission. Shown (top) is a dendritic segment with representative spines. As the schematic suggests with arrows to show potential changes, existing spine expansion, new spine formation, synaptic unsilencing, and formation of spine head protrusions represent post synaptic changes that might contribute to MMP and/or integrin dependent changes in the post synaptic element.](fncel-09-00305-g002){#F2}

Future studies related to CAM-integrin interactions will be necessary to examine a variety of additional questions including that of which integrin binding ligands are generated with learning and memory *in vivo.* Further study of whether ectodomain shedding plays and important role in select MMP dependent endpoints including changes in spine size or number ([@B147]; [@B177]), the development of spine head protrusions ([@B157]), and developmental changes in neurite outgrowth and dendritic arbor ([@B167]) may also be warranted. MMPs have also been linked to changes in neuronal excitability ([@B182]), and since integrin signaling can also influence ion channel function ([@B180]), this could represent a parallel topic for future exploration.

An additional avenue for exploration includes the question of whether the downstream effects of CAM shedding can synergize with events that follow from MMP-dependent processing of additional synaptic substrates. As an example, we consider protease activated receptor-1 (PAR-1). A select subset of MMPs target PAR-1, a G protein coupled receptor that is activated by cleavage in N-terminal domain and consequent exposition of a tethered peptide ligand ([@B171]; [@B151]). The receptor is expressed on select neuronal subpopulations and has been detected in synaptoneurosomes ([@B51]; [@B85],[@B86]). While activation of neuronal PARs has the potential to enhance GluN subunit phosphorylation and GluN function ([@B45]), whether PAR activation enhances neuronal integrin signaling is unknown. In non-neural cells, however, it has been shown that PAR-1 activation can enhance integrin affinity for ligands ([@B145]).

CAM Shedding: From Physiology to Pathology
==========================================

While regulated physiological release of MMPs can contribute to adaptive plasticity, it is important to note that dysregulated release has the potential to disrupt the same ([@B182]). Consistent with this, MMP inhibitors have been shown to ameliorate neuronal injury in a number of disease models. In many of these studies, however, reduced MMP-dependent damage to blood brain barrier integrity is likely to account for much of the observed neuroprotection ([@B7]). There is, however, an increasing appreciation synaptic proteolysis in particular as significant a contributor to neurological disease. To follow, we will briefly discuss two disorders in which altered synaptic proteolysis may be critical to disease expression. The first is fragile X syndrome (FXS) and the second is psychostimulant addiction.

Fragile X Syndrome
------------------

Fragile X syndrome is a leading genetic cause of intellectual disability and autism ([@B138]). At present, no cure is available. Symptoms include developmental delay and increased susceptibility to seizures, while pathological findings include relatively dense and immature dendritic spines ([@B41]; [@B94]; [@B117]; [@B138]). Expansion of the trinucleotide CGG repeat in excess of 200 repeats located in the 5′ untranslated region of the X chromosome-linked *FMR1* gene cause FXS ([@B172]; [@B155]). This leads to transcriptional silencing and a consequent lack of functional protein product, fragile X mental retardation protein (FMRP). FMRP regulates expression of a subset of dendritically localized mRNAs, and thus levels of dendritically localized proteins may be altered in FXS ([@B34]; [@B138]). FMRP generally acts to inhibit the translation of target genes, but in select cases it may have actions that lead instead to enhanced translation ([@B34]; [@B138]). For example, FMRP is thought to enhance translation of superoxide dismutase ([@B10]), and thus antioxidant enzyme activity might be reduced in FXS. This has implications for glial activation, which has been observed in association with the disease ([@B133]). Moreover, neuronal and/or glial expression of MMPs may be elevated in response to increased glial activation and/or oxidant stress ([@B48]).

Published studies have linked MMP activity to FXS. Levels of MMP-9 are increased in affected humans and in a murine model ([@B148]). Increased dendritic translation of MMP-9 has also been observed ([@B60]). Recent work suggests that expression of additional MMPs may be increased as well. For example, transcripts for MMP-2, -3, -7, -9, and -24 are increased in heavy polysomes from *Fmr1* mutant mice ([@B46]). In terms of functional consequences, dendritic spine abnormalities in a mouse model of FXS can be reduced by minocycline, an inhibitor of MMP activity that can access the brain ([@B17]). Spine abnormalities are also reduced in the background of MMP-9 deficiency ([@B148]). Moreover, exogenous MMP administration to cultured neurons has been associated with relevant changes in spine morphology ([@B18]). Interestingly, MMP knockout can also reduce neuronal circuit defects in a drosophila model of disease ([@B149]).

The mechanism(s) by which excess MMP activity stimulates the FXS phenotype have yet to be determined. Several possibilities have been suggested, including increased signaling by MMP-dependent activation of pro-neurotrophins and/or generation of integrin-binding laminin fragments ([@B148]). It is tempting to speculate, however, that excess generation of integrin-binding CAM fragments might play a role. Future studies to address this question may therefore be warranted.

Addiction
---------

Matrix metalloproteinase-dependent changes in synaptic structure and function are also thought to contribute to the maladaptive learning and memory associated with addiction to stimulants including methamphetamine. Methamphetamine is a widely abused illicit drug that has high addictive potential. A variety of studies suggest that methamphetamine is linked to metabolic changes in the brain as well as to synaptic injury ([@B128]; [@B174]; [@B26]). Evidence for increased MMP expression, release, and/or activation in the setting of methamphetamine exposure comes from several groups. This stimulant can increase release of MMP-1 from cultured neural cells ([@B32]). This observation is consistent with results from rodent studies in which methamphetamine stimulates increased binding of AP-1, a transcription factor critical to the expression of MMPs including MMP-1 ([@B3]). Additional studies have demonstrated that 5 days of exposure to the drug (2 mg/kg/day) is associated with increased MMP-2 and -9 protein in the frontal cortex and nucleus accumbens of rats ([@B101]). Moreover, an acute high dose of MA (40 mg/kg) is followed by increased mRNA expression of MMP-9 in murine CNS ([@B83]). Similarly, cocaine, which is similar to methamphetamine in its potential to increase catecholamine levels, has been shown to increase MMP-9 activity in the medial prefrontal cortex at 1, 3, and 24 h post-administration ([@B23]).

Methamphetamine has the potential to increase MMP expression through several non-mutually exclusive mechanisms including increased catecholamine dependent signaling, activation of glutamate receptor signaling, and increased oxidant stress. For example, methamphetamine associated increases dopamine can act on D1 type dopamine receptors to enhance substrate proteolysis ([@B59]). Since both D1 and D2 type are linked to βγ subunits that can activate PKC and release of intracellular calcium, activation of either receptor type might stimulate calcium dependent MMP release and/or PKC dependent activation of a transmembrane MMP. Another possibility is that MA increases levels of glutamate, as has been shown by Yamamoto and colleagues ([@B90]), and that glutamate signaling can in turn stimulate increased MMP expression and/or activity. Relatively high concentrations of MA also stimulate an increase in signaling by reactive oxygen intermediates ([@B78]), which can enhance both the expression and the activation of select MMPs ([@B48]).

Increased MMP activity may also contribute to synaptic and behavioral changes observed with stimulant exposure. It has been shown that methamphetamine-induced behavioral sensitization is reduced in mice lacking MMP-2 or MMP-9 ([@B102]). Protease activity has also been shown to contribute to cocaine associated CPP ([@B22]). In recent work focused on structural and function changes at the levels of the synapse in the setting of cocaine exposure paradigms, an increase in the AMPA/NMDA current ratio was increased in extinguished rats, and further increased 15 min following cue-induced reinstatement ([@B150]). An increase in the AMPA/NMDA ratio after extinction was restored to control by a selective MMP-2 inhibitor, while the altered reinstatement ratio was restored by either and MMP-2 or -9 inhibitor ([@B150]). Complementary measures of spine density and spine size supported a view in which MMP-2 could increase the density and head size of spines in extinguished animals and that MMP-9 activity contributed to an increase in spine size with reinstatement.

Overall, studies related to the role of MMPs in addiction are exciting and should stimulate further work to address underlying mechanistic components.

Summary
=======

Matrix metalloproteinases were named for their ability to cleave extracellular matrix proteins such as laminin and collagen. While matrix remodeling effects may be essential during development and wound healing, proteolysis of cell surface receptors including CAMs could represent a critical means by which MMPs can fine tune synaptic structure and function in a more stable or relatively mature CNS. This possibility is supported by work showing that neuronal activity stimulates proteolysis of synaptically localized CAMs, and that CAM shedding can influence varied measures of synaptic transmission. Future studies will be necessary to examine CAM cleavage as affected by variables including cell type, brain region, stimulus type/duration, and developmental stage. Future studies will also be necessary to determine which CAM cleavage products are most likely to influence MMP dependent plasticity *in vivo*, and to determine the extent to which CAM shedding combines with additional MMP-stimulated events to influence experience dependent plasticity.
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